Gene · 11280
Papers1,589
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,589
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparison of Nocifensive Behavior in NaV1.7-, NaV1.8-, and NaV1.9-Channelrhodopsin-2 Mice by Selective Optogenetic Activation of Targeted Sodium Channel Subtype-Expressing Afferents. | J Neurosci Res | 2024 | 39364619 | PubTator, text mining | PubMed |
| Giant Optical Anisotropy Induced by Magnetic Order in FePS3/WSe2 Heterostructures. | Small | 2024 | 39235385 | PubTator, text mining | PubMed |
| Enhanced Multifaceted Properties of Nanoscale Metallic Multilayer Composites. | Materials (Basel) | 2024 | 39203182 | PubTator, text mining | PubMed |
| Spider and scorpion knottins targeting voltage-gated sodium ion channels in pain signaling. | Biochem Pharmacol | 2024 | 39102991 | PubTator, text mining | PubMed |
| Genetic Analysis of SCN11A, SCN10A, and SCN9A in Familial Episodic Pain Syndrome (FEPS) in Japan and Proposal of Clinical Diagnostic Criteria. | Int J Mol Sci | 2024 | 38999942 | PubTator, text mining | PubMed |
| Nanomedicine and voltage-gated sodium channel blockers in pain management: a game changer or a lost cause? | Drug Deliv Transl Res | 2024 | 38861139 | PubTator, text mining | PubMed |
| Unique electrophysiological property of a novel Nav1.7, Nav1.8, and Nav1.9 sodium channel blocker, ANP-230. | Biochem Biophys Res Commun | 2024 | 38776832 | PubTator, text mining | PubMed |
| Prohibitin modulates periodontium differentiation in mice development. | Front Cell Dev Biol | 2024 | 38756696 | PubTator, text mining | PubMed |
| Elevated SCN11A concentrations associated with lower serum lipid levels in patients with major depressive disorder. | Transl Psychiatry | 2024 | 38734669 | PubTator, text mining | PubMed |
| Tunable, multifunctional opto-electrical response in multilayer FePS3/single-layer MoS2 van der Waals p-n heterojunctions. | Nanoscale Adv | 2024 | 38545296 | PubTator, text mining | PubMed |
| XPS Analysis of FexNiyPS3 vdW Materials Used in the Hydrogen Evolution Processes. | Chemphyschem | 2024 | 38526205 | PubTator, text mining | PubMed |
| Functionally-selective inhibition of threshold sodium currents and excitability in dorsal root ganglion neurons by cannabinol. | Commun Biol | 2024 | 38263462 | PubTator, text mining | PubMed |
| Electrostatic co-assembly of FePS3 nanosheets and surface functionalized BCN heterostructures for hydrogen evolution reaction. | Dalton Trans | 2024 | 38258579 | PubTator, text mining | PubMed |
| State-Dependent Blockade of Dorsal Root Ganglion Voltage-Gated Na+ Channels by Anethole. | Int J Mol Sci | 2024 | 38256108 | PubTator, text mining | PubMed |
| Pharmacologic Characterization of LTGO-33, a Selective Small Molecule Inhibitor of the Voltage-Gated Sodium Channel NaV1.8 with a Unique Mechanism of Action. | Mol Pharmacol | 2024 | 38195157 | PubTator, text mining | PubMed |
| Improving the efficiency of a CIGS solar cell to above 31% with Sb2S3 as a new BSF: a numerical simulation approach by SCAPS-1D. | RSC Adv | 2024 | 38192318 | PubTator, text mining | PubMed |
| Nav1.7 as a chondrocyte regulator and therapeutic target for osteoarthritis. | Nature | 2024 | 38172636 | PubTator, text mining | PubMed |
| Resurgent current in context: Insights from the structure and function of Na and K channels. | Biophys J | 2024 | 38130058 | PubTator, text mining | PubMed |
| Peptide toxins that target vertebrate voltage-gated sodium channels underly the painful stings of harvester ants. | J Biol Chem | 2024 | 38110035 | PubTator, text mining | PubMed |
| A structural atlas of druggable sites on Nav channels. | Channels (Austin) | 2024 | 38033122 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11280/papers?page=6